Objectives: Advanced prostate cancer (PC) is a frequent entity. The objectives of this paper are the presentation of a sample of patients with PC undergoing treatment with androgen deprivation therapy (ADT) in usual clinical practice and the determination of parameters associated with the development of resistance to castration (CRPC).
Material And Methods: Multicenter, observational, retrospective study that analyzes patients treated with ADT from January 2016 to January 2017.